The counter-regulatory effects of /3-adrenergic stimulation and cyclic AMP on the insulin-like action of growth hormone (GH) on the subcellular distribution of insulin-like growth factor II (IGF-II) receptors were studied in fat cells from hypophysectomized (Hx) and sham-operated rats. For comparison, the effect of insulin on this process was also studied. Basal IGF-II binding was increased by approx. 2-fold in cells from Hx as compared with sham-operated animals. The stimulatory effect of insulin was decreased in Hx cells, mainly due to a basal redistribution but also to a reduced total number of receptors. GH exerted an acute insulin-like effect in cells from Hx rats and stimulated the translocation of IGF-II receptors from an intracellular pool to the plasma membrane. ,-Adrenergic stimulation with isoprenaline or addition of the non-metabolizable cyclic AMP-analogue M-monobutyryl cyclic AMP induced a cellular resistance to both GH and insulin and also reduced the responsiveness to these hormones. Adenosine exerted a modulatory effect on both hormones. Binding of 125I-labelled GH to its receptors was not significantly changed by any of these factors. It is concluded that:
INTRODUCTION
Growth hormone (GH) has been shown to elicit a number of different insulin-like effects in rat fat cells. These effects include most of the known actions of insulin on glucose uptake and oxidation, as well as the anti-lipolytic effect (Birnbaum & Goodman, 1976; Goodman, 1981; Goodman & Coiro, 1981; Grichting et al., 1983; Gause et al., 1983 Gause et al., , 1985 Bjorgell et al., 1984; . The ability of GH to rapidly stimulate amino acid transport and protein synthesis is also attributed to its insulin-like action (Cameron et al., 1988) . The physiological significance of the insulin-like effects of GH is unclear since they can only be reproduced in vitro following preincubation in the absence of GH (Goodman & Coiro, 1981) or in cells from hypophysectomized (Hx) rats (Gause et al., 1983) . However, experiments in man have provided evidence for a rapid and important insulin-like effect of GH in vivo (Davidson, 1987) .
In addition to its metabolic effects, insulin has also been shown to increase the binding of insulin-like growth factor II (IGF-TI) to rat adipocytes (Zapf et al., 1978; King et al., 1980 . Detailed studies by Wardzala et al. (1984) showed that when receptor cycling was stopped by ATP depletion, the increased IGF-II binding was completely accounted for by an increased number of binding sites rather than by a change in affinity. Subcellular fractionation experiments also showed that insulin increases the number of binding sites through the translocation of IGF-II receptors from a large intracellular pool to the plasma membrane (Wardzala et al., 1984) .
We have shown previously that GH is also able to rapidly increase the number ofcell-surface IGF-II receptors in adipocytes from Hx rats without changing the receptor affinity (Lonnroth et al., 1987a) . This effect of GH displayed may similarities with that of insulin, but clear differences were also found with respect to kinetics and magnitude.
The effect of insulin on both glucose transport and translocation of IGF-II receptors to the plasma membrane is opposed by cyclic AMP and /3-adrenergic stimulation (Taylor et al., 1976; Kashiwagi et al., 1983; Green, 1983 , Kirsch et al., 1983 Kuroda et al., 1987; Lonnroth et al., 1987b,c) . There is evidence that the inhibition of insulin action is exerted partly through decreased insulin binding (Kirsch et al., 1983; Lonnroth & Smith, 1983; Pessin et al., 1983) and partly through an interaction with an early post-binding event, including attenuation of the receptor tyrosine kinase activity (Stadtmauer & Rosen, 1986; Haring et al., 1986) . In the present study we have characterized the interaction between GH an cyclic AMP in order to elucidate the possibility that the insulin-like effect of GH and the effect of insulin are exerted through similar mechanisms subsequent to the binding of the hormones to their receptors.
MATERIALS AND METHODS Materials
Human 'l25-labelled IGF-IT and unlabelled IGF-II were purified from serum as previously reported (Enberg et al., 1984) and were generously supplied by Dr (Smith, 1930) . Hx rats were injected subcutaneously with 2.25 ,ug of L-thyroxine and 75 ,ug of cortisol every day. The animals were killed by decapitation 3-4 days after the operation.
IGF-II binding
The epididymal fat pads were immediately excised and minced. Isolated adipocytes were obtained by incubating the minced tissue in medium 199 with BSA (40 mg/ml) and collagenase (1 mg/ml) at 37°C for 60 min. The cells were then filtered through a nylon mesh and washed four times in fresh medium. The preincubations were performed for 30 min at 37°C, with a lipocrit of around 100%, with or without the different agents indicated. Receptor cycling was then stopped by the addition of 2 mM-KCN 10 min prior to the binding assay. The cells were transferred to 24°C, 0.1-0.25 ng of 251I-IGF-II/ml was added and the incubations were carried out for 60 min when steadystate binding had been reached. The cell-associated radioactivity was determined in aliquots after separating cells and medium by centrifugation through silicone oil. Non-specific binding was estimated as the cell-associated radioactivity remaining in the presence of a large excess of unlabelled IGF-II (200 ng/ml) in the binding assay. This was subtracted from total binding to obtain specific binding.
GH binding
Binding of 125I-labelled hGH to isolated adipocytes was measured essentially as described by Fagin et al. (1980) with the modifications previously reported (Eden et al., 1982a) . hGH was iodinated by the lactoperoxidase method (Thorell & Johansson, 1971 ) to a specific radioactivity of 80-100 /tCi/,ug. The labelled hormone was purified over a Sephadex G-75 column on the day of the binding experiments. After preincubation as described above followed by the addition of 2 mM-KCN, 1.5 ml portions of the cells and medium were transferred to 24°C and mixed with 0.1 ml of medium containing approx. 3 ng of 125I-hGH with or without 10 ,tg of unlabelled hGH. After 2 h, portions of the cells and medium were layered over silicone oil and centrifuged in microfuge tubes (Gliemann et al., 1972) . Cell-associated radioactivity was measured and specific binding was determined by subtracting non-specific binding, estimated as radioactivity in the presence of 10 ,tg of unlabelled hGH, from total cell-associated radioactivity.
IGF-fl binding to solubilized receptors
In some experiments, cells preincubated as described above were solubilized essentially as reported by Marshall et al. (1985) but with some modifications. Portions of cells and medium were solubilized in 0.40% Triton X-100 for 60 min at 4°C in the presence of the protease inhibitors leupeptin (100 uM), pepstatin (70 ,uM), aprotinin (10 tg/ml) and phenylmethanesulphonyl fluoride (500 4aM). The receptors were precipitated together with
IgG by using poly(ethylene glycol). After repeated vortex-mixing, the samples were centrifuged at 11000 g for 5 min and the pellets were washed carefully three times. 
RESULTS
Binding of 125I-IGF-II to unstimulated cells from Hx rats was 1.0+0.7 pg/105 cells (mean+s.E.M., n = 7) which was approx 2-fold higher than the binding to cells from sham-operated animals (average increases 110 +43 0/o, n = 4).
Effect of insulin and the interaction with cyclic AMP Insulin markedly increased (10-15-fold) the number of binding sites for IGF-II in the sham-operated animals (results not shown). Insulin also increased IGF-II binding in cells from Hx rats (P < 0.01), but this effect was considerably smaller (approx. 3-fold increase) than that in the sham-operated animals (Fig. 1) . The marked insulin sensitivity in Hx cells is shown by the fact that 5 ,tunits/ml exerted almost a full stimulatory effect (approx. 80 % of the maximal binding) (Fig. 1) .
The non-metabolizable cyclic AMP analogue N6-mbcAMP markedly decreased IGF-II binding (-50 %o) in both the absence and the presence of insulin. Isoprenaline significantly reduced the effect of insulin, whereas binding in the absence of insulin was essentially unchanged (Fig. 1) isoprenaline more markedly decreased the effect of the submaximal insulin concentration (Fig. 1) , indicating induction of a marked insulin resistance.
Effect of GH and the interaction with cyclic AMP and adenosine The action of GH was only characterized in Hx cells, since its effect was too variable in the sham-operated animals (results not shown). GH elicited a consistent stimulatory effect in Hx cells (average increase 55 + 10 0/, n = 7, P < 0.01) (Fig. 2) . However, the responsiveness to GH was markedly attenuated in the presence of N6-mbcAMP, whereas isoprenaline produced a less marked inhibition (Fig. 2) .
ADA, which degrades the endogenous adenosine accumulating in the incubation medium, reduced unstimulated IGF-II binding as well as the responsiveness to GH to a similar extent as did the cyclic AMP analogue (Fig. 2) . Addition of the non-metabolizable adenosine analogue PIA completely restored IGF-II binding in both the absence and the presence of GH.
The dose-response relationship for the stimulatory effect of GH on IGF-II binding was also studied. The EC50 (concn. causing 50 % of maximal effect) for GH alone varied (12 + 5 ng/ml; n = 6), but both the cyclic AMP analogue (Fig.  3a) and isoprenaline (Fig. 3b) 
GH binding
The possibility that the attenuated sensitivity and responsiveness to GH ofIGF-II binding in the presence ofN6-mbcAMP, isoprenaline and ADA were due to an impaired ability of the hormone to bind to its receptor was also studied. However, as shown in Fig. 4 , incubation of adipocytes from Hx rats with these agents did not significantly change GH binding.
DISCUSSION
This study shows for the first time that the insulin-like effect of GH on IGF-II receptor distribution is inhibited by cyclic AMP and fl-adrenergic stimulation in a similar way as that of insulin itself. Our findings suggest that the insulin-like effect of GH shares a common pathway with insulin which occurs at the postbinding level.
Under the experimental conditions currently employed, where the cells are energy-depleted after preincubation with GH or insulin, the increased IGF-II binding is due to a rapid redistribution of the binding sites from an intracellular pool to the plasma membrane rather than to changed affinity (Wardzala et al., 1984 , Lonnroth et al., 1987a . The present data show that IGF-II binding to the total receptor pool from solubilized cells was unchanged whether or not the cells had been preincubated with GH or insulin.
In contrast with its acute insulin-like action, chronic GH exposure seems to exert an opposite effect, since IGF-II binding to Hx (GH-deficient) cells in the absence of hormones was increased by approx. 2-fold when compared with cells from sham-operated animals. This 2-fold difference clearly underestimates the redistribution of the IGF-IT receptors, since the total number of binding sites per cell, calculated from the binding to solubilized receptors, was decreased by approx. 40% in Hx animals. This may be due to a more general decrease in protein synthesis, since total cellular protein content was decreased to the same extent in these cells.
The effect of insulin on IGF-II binding was lower in Hx (GHdeficient) cells (3-fold increase in binding) as compared with cells from sham-operated animals (10-15-fold increase). A similar decrease in the insulin effect has been described in Hx cells for both insulin-stimulated glucose transport (Schoenle et al., 1979a,b) and insulin-stimulated redistribution of the glucose transporters (U. Smith, B. Kahn & S. Cushman, unpublished work), suggesting a more general effect of GH on the subcellular distribution of integral membrane proteins. However, when the reduction in the total cellular number of IGF-II receptors (40 %) as well as the subcellular redistribution of the receptors to the plasma membranes in unstimulated cells (approx. 2-fold) are considered, it becomes clear that insulin action per se is not impaired in Hx cells or by lack of GH. Taken together, these observations indicate that GH exerts a chronic regulatory effect, which is opposite to its acute insulin-like effect, on the subcellular distribution of the IGF-Il receptors between the plasma membrane and the intracellular pool. This concept is supported by our findings that giving GH to Hx rats reduced the stimulatory effect of GH on IGF-II binding in vitro (Lonnroth et al., 1987a) .
The present data on the adipocytes from Hx cells underscore the similarities between the effects of fl-adrenergic stimulation and cyclic AMP on insulin action and on the acute insulin-like effect of GH on IGF-II binding. Thus isoprenaline and N6-mbcAMP induce a clear rightward shift in the dose-response curves for both GH and insulin, suggesting an impairment in the signalling mechanisms. ,-Adrenergic stimulation and the cyclic AMP analogue also produce a significant reduction in the responsiveness to both hormones. However, some differences were seen between /J-adrenergic stimulation with isoprenaline and the effect of MV"-mbcAMP, which is not hydrolysed by the cyclic AMP phosphodiesterase (Beebe et al., 1984) . When added at a maximally effective concentration, N6-mbcAMP reduced IGF-II binding by approx 50% both in the basal, unstimulated state and in the presence of GH and insulin. Isoprenaline, on the other hand, did not affect basal unstimulated IGF-II binding but attenuated the effects of both insulin and GH. The reason for this discrepancy between the cyclic AMP analogue and isoprenaline might be that the latter, at least under some circumstances, can increase the endogenous release of adenosine from cells (Fredholm & Sollevi, 1981; Gidday et al., 1988) . Adenosine, in turn, exerts an insulin-like effect on both glucose transport and IGF-Il binding (Lonnroth et al., 1987b,c; Kuroda et al., 1987) . Additional support for this concept is provided by data showing that low concentrations of isoprenaline can stimulate glucose transport in the absence but not in the presence of ADA (Kashiwagi et al., 1983) . Removal of adenosine with ADA decreased IGF-Il binding to a similar extent as did the cyclic AMP analogue. The action of ADA was specifically due to adenosine removal, since concomitant addition of the non-metabolizable adenosine analogue PIA completely restored IGF-I1 binding to normal. Thus these findings suggest that adenosine, through its action on an inhibitory GTP-binding protein (G1) not only influences insulin action but also facilitates the insulin-like effect of GH.
GH has been shown to exert its effects through an interaction with its specific receptor without cross-reacting with receptors for other peptide hormones (Fagin et al., 1980; Eden et al., 1982b) . Neither /J-adrenergic stimulation nor exposure to the cyclic AMP analogue induced any significant change in GH binding, even though they shifted the dose-response curve for GH to the right.
Recently, Gorin et al. (1988) reported that both /-adrenergic stimulation and cyclic AMP reduced GH binding to rat fat cells. However, in that study, the cells were exposed to the adrenergic agents for a longer time than was used in the present investigation. Furthermore, receptor internalization was not blocked before the binding assay. Still, when the time course for the effect of these agents on GH binding was analysed, it is clear that exposure to dibutyryl cyclic AMP for 30 min only slightly decreased binding (to approx. 80 % of control). In the present study, GH binding was measured after stopping receptor internalization and recycling through energy depletion. This approach probably better reflects cell-surface GH binding under the defined preincubation conditions used. Our data, therefore, indicate that the resistance to GH occurs at a level distal to the GH-binding site. This observation, together with the many similarities in the effects exerted by ,-adrenergic stimulation and the cyclic AMP analogue on GH and insulin action, suggests the existence of a common post-receptor pathway for these hormones. This is also supported by the similar mechanisms of action at the molecular level of both insulin and the insulin-like effect of GH with regard to the dephosphorylation of the hormone-sensitive lipase as a mechanism for their anti-lipolytic effect (Bjorgell et al., 1984) .
It is tempting to speculate that cyclic AMP interacts with an early post-binding phosphorylation event elicited by both GH and insulin, since ,-adrenergic stimulation and cyclic AMP interfere with the tyrosine kinase activity of the insulin receptor (Stadtmauer & Rosen, 1986; Haring et al., 1986) . Recent data have also demonstrated an autophosphorylation of the GHreceptor at tyrosine sites in response to GH (Foster et al., 1988 (D. Tornqvist, unpublished work) . One possibility which would reconcile these observations is the existence of a subgroup of GH receptors carrying tyrosine kinase activity.
In conclusion, the present study demonstrates marked similarities between insulin and GH action, including counterregulation by cyclic AMP. The data indicate a common postreceptor pathway for these hormones.
